AVENUE THERAPEUTICS, INC. Uncategorized Contracts & Agreements

17 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
At the Market Offering Agreement, dated May 10, 2024, by and between Avenue Therapeutics, Inc. and H.C. Wainwright & Co., LLC
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2024
Form of Investor Inducement Letter
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
2024
Description of Securities of Avenue Therapeutics, Inc
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2024
Form of November 2023 Investor Inducement Letter
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
2024
Form of January 2023 Investor Inducement Letter
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
2024
Description of Securities of Avenue Therapeutics, Inc
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2023
Placement Agent Agreement entered into by and between the Company and Aegis Capital Corp., dated January 27, 2023
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2023
Form of Lockup Agreement
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
2023
Description of Securities of Avenue Therapeutics, Inc
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2022
Description of Securities
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2021
Description of Securities
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2020
Form of CVR Agreement
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
DE
2019
Restrictive Covenant Agreement, dated as of November 12, 2018, by and between Dr. Lucy Lu, M.D. and InvaGen Pharmaceuticals Inc
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
DE
2018
Restrictive Covenant Agreement, dated as of November 12, 2018, by and between Fortress Biotech, Inc. and InvaGen Pharmaceuticals Inc
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
2018
Stockholders Agreement, dated as of November 12, 2018, by and between Avenue Therapeutics, Inc., Fortress Biotech, Inc., Dr. Lucy Lu, M.D. and InvaGen Pharmaceuticals Inc
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
DE
2018
Avenue Therapeutics, Inc. 2 Gansevoort Street, Th Floor, New York, NY 10014 www.avenuetx.com
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
2017
Amendment 2 to Asset Transfer andLicense Agreement
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
2017